to address the molecular mechanisms by which the trane11 ( Figure 1C ). Transcripts for GATA3 are also transient signaling gradients establish the transcriptional siently detected in the pituitary, showing ventral expresprograms that dictate cell type specification. In this pasion similar to that of GATA2 at e10.5, but become per, we demonstrate that two induced factors, Pit1 and undetectable by e13.5, prior to the appearance of the GATA2, by reciprocal interactions and based on both initial markers of ventral cell determination ( Figure 1D ). DNA binding-dependent and -independent actions, Double-label immunohistochemistry colocalizes expresprovide the molecular memory in vivo that mediates the sion of GATA2 protein in the adult pituitary to the two effects of transient signaling gradients in determining most ventrally arising cell types, gonadotropes and Pit1-pituitary cell types. dependent thyrotropes ( Figure 1E ).
Based on the ventral induction of a series of transcription factors, including GATA2, we examined in vivo Results
whether dorsally expanding the expression of the ventral signaling molecules BMP2 or Shh under control of 15 BMP2 Induces Ventral Expression of GATA2 kb ␣GSU 5Ј-flanking information, which targets expresTo investigate the hypothesis that morphogen-induced sion to Rathke's pouch and later to thyrotropes and transcription factors mediate the determination of pitugonadotropes, would dorsally expand specific ventrally itary cell types, we explored the transcription factorinduced genes. BMP2, normally expressed at the ventral encoding genes initially expressed at the ventral boundboundary of Shh restriction out of the nascent Rathke's ary of the developing Rathke's pouch. In vivo data have pouch, is required for the appearance of four pituitary suggested that pituitary cell type positional determinacell types (Ericson et al., 1998; Treier et al., 1998) . We tion can occur between e10.5-e12.5, long before termifind that expression of BMP2/4 under control of ␣GSU nally differentiated cell types appear between e15.5-results in a dramatic transcriptional induction as well as e16.5 ( Figure 1A) . We observed that the gene encoding dorsal expansion of GATA2 gene expression ( Figure 1F ), the zinc finger protein GATA2 exhibits ventral induction whereas other ventrally expressed genes are not directly in the pituitary coincident with the closure of Rathke's induced. In contrast, overexpression of Shh in vivo under pouch at e10.5 and is maintained with highest expres-␣GSU does not lead directly to transcriptional induction sion levels ventrally throughout early pituitary developof GATA2 ( Figure 1F ). These data are consistent with ment ( Figure 1B) , later becoming expressed diffusely as the hypothesis that expression of GATA2 in the pituitary the adult pituitary cell populations lose spatial restricis selectively induced in response to the ventral BMP2 tion. GATA2 therefore exhibits ventral inductive patterns signal, with highest levels of GATA2 present in the most similar to the genes encoding the transcription factors Brn4, Isl1, and P-Frk as well as ␣GSU between e10.5-ventral cell type, the presumptive gonadotrope precursors. 
Dorsal Expression of GATA2 Converts Pituitary
GATA2 animals, including the ventral lineage marker Isl1 and the gonadotrope marker SF1 ( Figure 2C ). ConCell Types to Gonadotropes If GATA2 were to represent the critical factor that mediversely, there is marked inhibition of Pit1 gene expression (Figures 2A and 2C ). Double labeling with antibodates the signal gradient-induced ventral determination program, then it should potentially be alone sufficient ies to define cells expressing the HA-tagged GATA2 transgene reveals that adult pituitaries contain predomito impose this program on the more dorsally located Pit1 cell lineages. We therefore targeted expression of nantly gonadotrope cells (Ͼ90% of total cells) and that all GATA2-expressing cells derived from the transgene GATA2 in vivo using 15 kb of Pit1 5Ј-regulatory information (Rhodes et al., 1993) to test whether extending the (HA positive) also express ␣GSU ( Figure 2D ). There is also a late appearance of some TSH␤-positive cells expression of GATA2 more dorsally would be sufficient to alter the fate of the Pit1-dependent cell types that (data not shown). These results demonstrate that GATA2 is alone sufficient to induce the gonadotrope fate in the would normally generate somatotropes, lactotropes, and thyrotropes. Analysis of pituitary glands from animals context of the more dorsally arising cell lineages and suggest an epistatic relationship between GATA2 and expressing the Pit1/GATA2 transgene reveals that initial activation of growth hormone, prolactin, and Pit1-depenthe remainder of the gonadotrope transcriptional program. In contrast, targeting of the ventrally induced hodent thyroid-stimulating hormone ␤ fails to occur at e16.5 (Figure 2A) , remaining undetectable at P 0 (Figure meodomain factor Isl1 under the identical promoter fails to convert the Pit1 lineages to gonadotropes (data not 2B) and in the adult. In contrast, whereas the terminal differentiation marker for gonadotrope development, shown) or inhibit Pit1 expression, demonstrating that the induction of the gonadotrope program is a specific LH␤, is normally restricted to the most ventral portion of the gland at P 0 in wild-type animals, the pituitary effect of GATA2. glands of Pit1/GATA2 mice exhibit a dramatically expanded gonadotrope population, extending dorsally
GATA2 Restriction of Pit1 Initial Activation
The conversion of the Pit1 lineage by GATA2 to a gonad- (Figures 2B and 2C) .
In parallel, a series of markers normally confined to otrope fate, despite normal expression of GATA2 in both gonadotropes and thyrotropes, is potentially explained ventral expression also exhibit dorsal expansion in Pit1/ (GH) promoter, after Pit1 autoregulation commences, results in transgenic embryos displaying high levels of GATA2 expression in the presumptive somatotrope region but maintains normal expression of growth hormone and Pit1 and no alterations from the normal expression of other cell type markers at e18.5 ( Figure 3A) . Thus, expression of GATA2 following terminal differentiation of a specific cell type (somatotropes) fails to alter the normal transcriptional programs or affect Pit1 gene expression once it is driven by the late, autoregulatory gene enhancer. 
Role of GATA2 in the Determination of Ventral Pituitary Cell Types

Pit1 Can Convert Gonadotropes to Thyrotropes
Based on the requirement for Pit1 function in thyrotrope by the marked inhibition of Pit1 gene expression in Pit1/ GATA2 animals (Figures 2A and 2B ). Pit1 gene expresdevelopment (Li et al., 1990 ) and its absence in the gonadotrope, we next wished to test whether extending sion is initially activated on e13.5 under control of a specific early gene enhancer but subsequently requires the expression domain of Pit1 to include the field of GATA2 ϩ cells from which the gonadotropes are deteran autoregulated distal enhancer between e16.5-e17.5 (DiMattia et al., 1997). If GATA2 were to act by suppresmined would "switch" their determination from a gonadotrope to a thyrotrope phenotype. Using 15 kb of ␣GSU sion of the Pit1 early-but not autoregulatory-enhancer, then GATA2 might fail to induce a cell type switch once regulatory sequences to target ventral expression of Pit1, we analyzed transgenic founder animals on e18.5, Pit1 autoregulation begins at the time of terminal differentiation (e16.5-e17.5). Indeed, targeting GATA2 expresexpressing Pit1, as determined using an in situ probe specific for the transgene (rPit1; Figure 4A ). Pituitaries sion under control of 1.7 kb of the rat growth hormone Q54A) based on its DNA-bound crystal structure (Jacobcritical function of the Pit1 homeodomain includes its ability to selectively alter components of gene activation son et al., 1997) that prevents DNA binding and DNA binding-dependent activation but has no effect on interprograms required for cell type specification through protein-protein interactions, in this case interacting with action with GATA2 ( Figure 6B ) and targeted its expression under control of ␣GSU regulatory sequences. As GATA2, inhibiting activation of gonadotrope-specific genes in thyrotropes. shown in Figure 6C , TSH␤ continues to be expressed normally in thyrotropes, indicating that the expression of the Pit1 DBmut does not act to "squelch" the binding or interaction with GATA2 suggest a bipartite interaction surface, including the basic cluster of amino acids preOur data suggest that the ventral→dorsal BMP2 gradient induces GATA2 in a corresponding gradient in preceding the first helix of the homeodomain and the N-terminal portion of the second helix, consistent with sumptive gonadotropes and thyrotropes and that the high levels of GATA2 in the most ventral aspect of the the ability of Pit1 to bind cognate DNA sites even in the presence of excess GATA2. In contrast, the inhibition gland directly or indirectly restricts Pit1 gene expression out of the presumptive gonadotropes, creating the critiof GATA2 binding in the presence of Pit1 reflects an interaction interface of GATA2 that is its DNA-binding cal delineation of the gonadotrope and Pit1 cell lineages. In the absence of Pit1, GATA2 expression appears suffisurface. However, a subset of Pit1-and GATA2-dependent genes, such as TSH␤, which have adjacent binding cient to induce the entire set of transcription factors that are typical of the gonadotrope cell type, including the sites for both proteins, escape this inhibiting effect. This is apparently due to allosteric effects imparted by the transcription factors SF1, P-Frk, and Isl1. Conversely, the absence of GATA2 dorsally is critical for differentiabinding of Pit1 to DNA sites that permit a Pit1-GATA2 conformation that no longer inhibits specific DNA bindtion of Pit1 ϩ cells to somatotrope/lactotrope fates, as the targeting of GATA2 more dorsally inhibits initial Pit1 ing by GATA2. Thus, Pit1-GATA2 protein-protein interactions can lead to gene-specific actions that have expression and converts these cells to gonadotropes. Similarly, targeting overexpression of BMP2/4 also income to assume cell-specific roles. We therefore suggest that a critical component of the hibits Pit1 expression, although the cell types fail to terminally differentiate (Treier et al., 1998). We hypothesize cell type determination program is achieved through the inhibition by Pit1 of GATA2-dependent gonadotropethat the level of GATA2 expression in the thyrotropes, however, is below the threshold required to inhibit actispecific genes while simultaneously permitting GATA2-dependent gene activation critical for establishing the vation of the Pit1 gene early enhancer, permitting the emergence of a Pit1 ϩ , GATA2 ϩ cell, dictating a pattern thyrotrope phenotype. Two types of in vivo data support a DNA binding-independent role of Pit1. The first is that of gene expression that defines a thyrotrope. This interpretation is supported by the ability to convert a gonadotargeted expression of a non-DNA-binding form of Pit1, still capable of interaction with GATA2, inhibits the trope to a thyrotrope cell fate by ventral extension of Pit1 expression to the Pit1 Ϫ , GATA2 ϩ field.
gonadotrope-specific terminal differentiation program, while point mutations that abolish the Pit1-GATA2 interThus, between e13.5-e17.5, Pit1 ϩ , GATA2 Ϫ cells will terminally differentiate to somatotropes/lactotropes; action revert this inhibitory effect. Second, this hypothesis receives genetic confirmation based on developPit ϩ , GATA2 ϩ cells to thyrotropes; and GATA2 We suspect that these DNA binding-dependent and TTTTTC-3Ј). DNA binding assays were performed using ␥-32 P--independent actions of Pit1 will prove to be prototypic labeled ATP double-stranded and gel-purified oligonucleotides as previously described (Rhodes et al., 1993) . Other reporter constructs of the actions of many highly expressed transcriptional and DNA sites used in this study have been described previously regulatory factors in the development of other mamma- (Rhodes et al., 1993) lian organs.
Immunoprecipitations and Protein Interaction Assays Experimental Procedures
For coimmunoprecipitation studies, 100 mm plates of pituitary GC cells were transfected with 5 g of a CMV-HA-GATA2 expression Plasmid Constructions for Transgenic Animals vector using the Lipofectamine Plus reagent (GIBCO-BRL). After 48 Plasmid DNA for generation of transgenic mice were constructed hr, cells were harvested and lysed in 600 l binding buffer containing by insertion of cDNAs into a vector cassette containing a 5Ј-␤-20 mM Tris (pH 7.8), 150 mM NaCl, 0.1% NP-40, 10% glycerol, 0.5 globin intron and a 3Ј-polyadenylation signal from the human growth mM EDTA, and 1ϫ Complete Protease Inhibitor Cocktail (Boehringer hormone gene as previously described (Treier et al., 1998) . The Mannheim). Lysates were incubated with 3 l of rabbit polyclonal murine GATA2 cDNA was obtained by PCR amplification of e14.5 ␣-Pit1 antiserum for 8 hr at 4ЊC, precipitated with protein A/G plus pituitary cDNA and cloned in frame with the HA epitope at the N agarose, and washed four times in binding buffer. Complexes were terminus. The dnGATA2 transgene was constructed by fusion of the resolved by 8% SDS-PAGE and transferred to nitrocellulose memEngrailed repressor domain (aa 2-229) to the DNA-binding region branes. GATA2 was detected using an ␣-HA monoclonal antibody and C terminus of GATA2 (aa 260-481). For the Pit1 transgenic (Babco) at a 1:3000 dilution, followed by anti-mouse HRP-coupled constructs, the full-length 1.6 kb rat cDNA was used, and point secondary antibodies (1:3000), and developed by ECL (Amersham). mutations were generated using the Quick Change Mutagenesis kit Protein preparation and interaction studies were performed as (Stratagene).
described (Kamei et al., 1996) . Fragments encoding the full-length Pit1 (aa 1-291), the homeodomain of Pit1 (aa 206-291), and the Generation of Transgenic Animals zinc finger region plus the C terminus of GATA2 (aa 291-481) were Plasmid DNA for transgenic constructs was prepared by standard generated by PCR amplification and cloned in frame into the GST procedures, purified by gel electrophoresis, dialyzed against 10 mM expression plasmid pGEX2TK (Pharmacia). Fragments of Pit1 and Tris (pH 7.5), 1 mM EDTA, and microinjected as described (Crenshaw GATA2 for mapping interaction domains were also generated by et al., 1989). Founder animals were analyzed for integration by PCR PCR and cloned into the plasmid pCDNA3-KATG for in vitro tranand Southern blot analysis. All transgenic animals used in this study scription and translation from rabbit reticulocyte lysates using were determined to have integrated approximately three to ten cop-35 S-labeled methionine (Promega). Point mutations in Pit1 and ies of the transgene. Data for the Pit1/GATA2 transgene were obtained from two independent transgenic lines, showing similar levels GATA2 were generated using the Quick Change Mutagenesis kit 
